Insulin potentiation therapy for cancer?

Lancet Oncol. 2019 Feb;20(2):191-192. doi: 10.1016/S1470-2045(19)30003-8.

Authors

Tristan M Sissung¹, Keith T Schmidt¹, William D Figg²

Affiliations

¹ Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: [email protected].

PMID: 30712796
DOI: 10.1016/S1470-2045(19)30003-8

No abstract available

MeSH terms

Drug Synergism
Humans
Insulin / therapeutic use*
Neoplasms / drug therapy*
Quackery*

Substances

Insulin